Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,595 | Dovepress* | 9,904+ | 1,704 | 11,608 | |
| PubMed Central* | 2,691 | 508 | 3,199 | ||
| Totals | 12,595 | 2,212 | 14,807 | ||
| *Since 23 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar